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Caspase-11 is a highly inducible caspase that con-
trols both inflammatory responses and cell death.
Caspase-11 controls interleukin 1b (IL-1b) secretion
by potentiating caspase-1 activation and induces
caspase-1-independent pyroptosis downstream of
noncanonical NLRP3 inflammasome activators
such as lipopolysaccharide (LPS) andGram-negative
bacteria. However, we still know very little about the
downstream mechanism of caspase-11 in regulating
inflammation because the known substrates of
caspase-11 are only other caspases. Here, we iden-
tify the cationic channel subunit transient receptor
potential channel 1 (TRPC1) as a substrate of cas-
pase-11. TRPC1 deficiency increases the secretion
of IL-1b without modulating caspase-1 cleavage or
cell death in cultured macrophages. Consistently,
trpc1/ mice show higher IL-1b secretion in the
sepsis model of intraperitoneal LPS injection. Alto-
gether, our data suggest that caspase-11 modulates
the cationic channel composition of the cell and thus
regulates the unconventional secretion pathway in a
manner independent of caspase-1.
INTRODUCTION
Inflammatory responses activated by the innate immunity sys-
tem constitute a highly efficient barrier in defending against
diverse organismal insults. During an innate immune response,
early local detection of the insult is mediated by the activation
of pattern recognition receptors (PRRs) by pathogen- and
damage-associated molecular patterns, which then triggers
inflammation by stimulating the production and release of proin-
flammatory cytokines such as interleukin 1b (IL-1b), as well as
pyroptosis, a proinflammatory form of cell death (Keller et al.,
2008; Kepp et al., 2010; Martinon et al., 2009). Inflammation,1122 Cell Reports 6, 1122–1128, March 27, 2014 ª2014 The Authorshowever, must be tightly regulated, as excessive or chronic
inflammation may lead to detrimental outcomes, including tissue
damage or death as a result of septic shock.
Caspase-11, a member of the caspase family of cysteine pro-
teases, is a critical mediator of inflammation and cell death (Kang
et al., 2000; Wang et al., 1998). Casp11/mice are highly resis-
tant to lipopolysaccharide (LPS)-induced septic shock, but are
more sensitive to infection with Burkholderia, a cytosolic bacte-
rium that escapes the vacuole, demonstrating the inflammatory
response as a ‘‘double-edged sword’’ (Aachoui et al., 2013;
Wang et al., 1998). Caspase-11 is highly inducible by activators
of innate immunity such as LPS, interferon g (IFN-g), and IFN-b
(Kang et al., 2000, 2002; Lee et al., 2001; Rathinam et al.,
2012; Wang et al., 1996). The expression of caspase-11 is
required for caspase-1 activation and subsequent IL-1b secre-
tion downstream of a subgroup of stimuli (Wang et al., 1998).
Caspase-1 is directly involved in the processing of pro-IL-1b
and the secretion of IL-1b. Caspase-11 potentiates caspase-1
activation downstream of noncanonical NLRP3 inflammasome
activators, including diverse Gram-negative bacteria such as
Escherichia coli (Kayagaki et al., 2011; Wang et al., 1998), but
is dispensable for the activation of caspase-1 downstream of
canonical NLRP3 inflammasome activators such as extracellular
ATP, the lysomotropic agent HLLOMe, and silica crystals, as
well as other canonical inflammasome complexes such as
the NLRC4 or AIM2 inflammasomes. In addition, caspase-11
triggers caspase-1-independent pyroptosis and subsequent
release of proinflammatory factors such as IL-1a and HMGB1
downstream of noncanonical stimuli, including several vacuolar
and cytosolic Gram-negative bacteria (Aachoui et al., 2013;
Broz et al., 2012; Case et al., 2013; Kayagaki et al., 2011). Finally,
caspase-11 modulates actin cytoskeleton dynamics and re-
stricts Legionella pneumophila growth by promoting bacterial
vacuole fusion with lysosomes, as well as by regulating cell
migration (Akhter et al., 2012; Li et al., 2007). Caspase-11, which
was first characterized in the late 1990s (Wang et al., 1996,
1998), has recently received much attention (Broz et al., 2012;
Rathinam et al., 2012). However, the downstream molecular
effectors of caspase-11 remain to be identified. To the best of
Figure 1. Caspase-11 Interacts with TRPC1
(A) Lysates of HEK293T cells expressing HA-
TRPC1 and FLAG-Casp11 were subjected to anti-
HA immunoprecipitation. The western blots were




FLAG-Casp11-p20, or FLAG-Casp11-p10 were
subjected to anti-HA immunoprecipitation. The
western blots were analyzed using anti-FLAG
and anti-HA.
(C) Lysates of HEK293T cells expressing FLAG-
Casp11 and HA-TRPC1, HA-TRPC1-N, HA-
TRPC1-DC, HA-TRPC1-DN, or HA-TRPC1-TM
were subjected to anti-HA immunoprecipitation.
Diagrams of TRPC1 association with membrane
and truncation expressionconstructs of TRPC1are
shown; gray sections represent transmembrane
spans. Thewestern blotswere analyzed using anti-
caspase-11 and anti-HA.
See also Figure S1.our knowledge, caspase-3 and caspase-11 itself are the only
reported substrates for caspase-11 (Kang et al., 2000).
Transient receptor potential channel 1 (TRPC1) belongs to the
canonical TRP subfamily of proteins with six transmembrane
domains that assemble to form cation-permeable pores as
homo- or heterotetramers (Clapham, 2003). TRPC1 associates
with other TRP channels, such as TRPC4 and TRPC5, as well
as scaffolding proteins (Stru¨bing et al., 2001). The composition
of these complexes determines the distribution of TRPC1
between the endoplasmic reticulum (ER) and the plasma mem-
brane, as well as the various characteristics and gating mecha-
nisms of the channels in which TRPC1 takes part. Although
TRPC1 is widely expressed in a variety of tissues and is known
to contribute to various physiological functions, it was not known
to be involved in innate immunity.
Here, we identify TRPC1 as a substrate for caspase-11 that
regulates inflammatory responses. Upon LPS treatment, cas-
pase-11 induction leads to the degradation of TRPC1 in macro-
phages. TRPC1-deficient macrophages secrete increased
amounts of mature IL-1b in response to NLRP3 activators
without affecting caspase-1 cleavage or pyroptosis. In addition,
trpc1/mice show higher IL-1b secretion in their sera following
LPS injection. Our data provide a mechanism whereby caspase-
11 promotes IL-1b release by degrading TRPC1 independentlyCell Reports 6, 1122–1128of caspase-1, and suggest that TRPC1
plays a role in regulating innate immunity
by modulating channel complexes during
inflammatory responses.
RESULTS
TRPC1 Is a Substrate for
Caspase-11
A yeast two-hybrid screen identified
TRPC1 as an interacting protein of inflam-
matory caspases (data not shown). Whencoexpressed in human embryonic kidney 293T (HEK293T) cells,
the larger isoformofpro-caspase-11 (p43) coimmunoprecipitated
with hemagglutinin-TRPC1 (HA-TRPC1; Figure 1A). This interac-
tion of TRPC1 with caspase-11 is selective because, among all
TRPC channels, only TRPC1 and (with a lower affinity) TRPC2
could be immunoprecipitated with caspase-11 (Figure S1). Sub-
units p10 and p20 of caspase-11, but not caspase recruitment
domain (CARD) alone, could be coimmunoprecipitated with
TRPC1 (Figure 1B). TRPC1 contains six transmembrane domains
in its central part and two large N- and C-terminal cytosolic
domains (Beech, 2005). FLAG-caspase-11 was able to coimmu-
noprecipitate independently with HA-TRPC1 N-terminal (HA-
TRPC1-N) alone, the N-terminal domain with the transmembrane
domain (HA-TRPC1-DC), and the transmembrane domain with
the C-terminal domain (HA-TRPC1-DN), but not with the central
transmembrane domain alone (HA-TRPC1-TM; Figure 1C).
Since the catalytic domain (p20+p10) of caspase-11 interacts
with the TRPC1 channel, we hypothesized that TRPC1 may be a
substrate for caspase-11. Indeed, coexpression of caspase-11
and TRPC1 in HEK293T cells greatly decreased the levels of
TRPC1 protein, which were restored upon addition of the
caspase inhibitor z-VAD.fmk (Figure 2A). Notably coexpression
of the proteolytically inactive mutant caspase-11C255G did not




C Figure 2. TRPC1 Is a Substrate of Caspase-
11 and Degraded following LPS Treatment
(A) HEK293T cells were cotransfected with expres-
sion vectors of HA-TRPC1 and FLAG-Casp11 or
Casp11C255Gcatalyticmutant,andcultured for48hr.
z-VAD.fmk (20 mM) was added as indicated for the
last 24 hr of culture. The levels of HA-TRPC1 pro-
tein were assessed by western blotting using anti-
HA, anti-caspase-11, and anti-actin (as a control).
(B) In vitro cleavage assay of 35S-labeled TRPC1 by
purified recombinant caspase-11 p30.
(C) TRPC1 is not a substrate of caspase-1. In vitro
cleavage assay of 35S-labeled TRPC1 by recombi-
nant caspase-1 p30.
(D–F) Macrophages from WT (D) or casp11/ or
casp1/ casp11/mice (E) were treated with LPS
(100 ng/ml) for 16 hr. Macrophages from WT mice
were infectedwithE.coli (J53strain,moi20) for 16hr
(F). The expression levels of endogenous TRPC1
were assessedbyanti-TRPC1 immunoprecipitation
followed by anti-TRPC1 western blotting.
See also Figure S2.of purified recombinant caspase-11 p30with S35-labeled TRPC1
in vitro led to the appearance of multiple TRPC1 fragments and
a reduction of full-length TRPC1, which was inhibited by
z-VAD.fmk (Figure 2B). On the other hand, recombinant cas-
pase-1 did not cleave TRPC1 in vitro, although it effectively
cleaved pro-IL-1b (Figures 2C and S2A). Coexpression of
TRPC1 with caspase-1 did not lead to a reduction of TRPC1,
contrary to that observed with caspase-11 (Figure S2B),
although overexpressed caspase-1 could be coim-
munoprecipitated with overexpressed TRPC1 (Figure S2C).
Thus, TRPC1 is a substrate for caspase-11, but not caspase-1.
Given that the expression of caspase-11 is highly inducible by
LPS (Wang et al., 1996), we next assessed the cleavage and
levels of TRPC1 in LPS-treated cells. Ectopic HA-TRPC1 protein
levels were substantially reduced 8 hr following LPS treatment,
but not in the presence of the pan caspase inhibitor z-VAD.fmk
or IDUN-6556, suggesting that TRPC1 is degraded by inflamma-
tory caspases (Figure S2D). Consistently, the levels of endoge-
nous TRPC1 protein decreased in primary macrophages upon
LPS treatment, which induced the expression of caspase-11
(Figure 2D). Strikingly, TRPC1 remained stable in casp1/
casp11/, and casp11/ macrophages treated with LPS (Fig-
ure 2E). On the other hand, the amounts of trpc1 mRNA re-
mained unchanged following LPS treatment of both wild-type
(WT) and casp11/ macrophages, excluding the possibility
that TRPC1 is regulated at the transcriptional level (Figure S2E).
Furthermore, we found that stimulation of primary macrophages
with E. coli (J53 strain), which induced the expression of cas-
pase-11, also led to a reduction in the levels of endogenous
TRPC1 protein (Figure 2F). Notably, TRPC1 levels remained sta-
ble in WT macrophages treated with low-dose LPS (1 ng/ml) for
3.5 hr followed by ATP, which was sufficient to lead to the secre-
tion of caspase-1, but not sufficient to induce the expression of
caspase-11 (Figure S2F). On the other hand, TRPC1 was
degraded in WT, but not casp11/, macrophages treated with
high-dose LPS (100 ng/ml) for 16 hr followed by ATP, which
was sufficient to lead to expression of caspase-11 (Figure S2F).
Thus, caspase-1 activation in the absence of caspase-111124 Cell Reports 6, 1122–1128, March 27, 2014 ª2014 The Authorsexpression does not lead to TRPC1 degradation. Taken
together, these results suggest that TRPC1 is a physiologically
relevant substrate of caspase-11 and is degraded in a
caspase-11-dependent manner in macrophages upon induction
of caspase-11 after the activation of TLR signaling.
Caspase-11 Controls the TRPC1-Dependent Decrease
in Cytosolic Ca2+ following LPS Treatment
Since TRPC1 is a membrane protein that can form channels
permeable to Ca2+, we next assessed the effect of TRPC1 and
caspase-11 on macrophages’ cytosolic Ca2+ concentration in
response to LPS stimulation. We found that during continuous
LPS treatment, cytosolic Ca2+ concentration demonstrated a
transient increase at 2 hr followed with a sustained decrease for
up to 10 hr (Figure 3A). Interestingly, this sustained decrease of
Ca2+ concentration is dependent on caspase-11 and TRPC1, as
no reduction of cytosolic Ca2+ concentration was observed in
either trpc1/orcasp11/macrophagesat10hrafterLPStreat-
ment (Figure 3B). Thus,weconclude that TRPC1cleavagebycas-
pase-11hasa functional impactonCa2+fluxafter LPSstimulation.
TRPC1 Deficiency Promotes IL-1b Release but Has No
Effect on Caspase-1 Activation or Pyroptosis
Next, we investigated the implication of TRPC1 in the inflamma-
tory response regulated by caspase-11. Caspase-11 is a critical
mediator of LPS-induced septic shock (Wang et al., 1996, 1998);
therefore,wefirst assessed the responseof trpc1/mice to intra-
peritoneally injected LPS. Indeed, trpc1/ mice showed signifi-
cantly higher levels of IL-1b in serum following LPS injection as
comparedwithWTmice, indicating thatTRPC1modulates inflam-
mation invivoby inhibiting IL-1b secretion (Figure4A).On theother
hand, trpc1/ mice did not exhibit higher constitutive levels of
circulating IL-1b in basal conditions, suggesting that the absence
of TRPC1 alone is not sufficient to elicit an inflammatory response
(Figure S3A). At the cellular level, caspase-11 is required for cas-
pase-1 activation, IL-1b and IL-18 secretion, and pyroptosis in
macrophages infectedwith E. coli (Kayagaki et al., 2011). Consis-
tently, trpc1/macrophages showed higher secretion of mature
Figure 3. LPS Triggers a Caspase-11- and
TRPC1-Dependent Cytosolic Ca2+Decrease
(A) Macrophages from WT mice were treated with
LPS (100 ng/ml) for the indicated times. Intracel-
lular Ca2+ was measured through ratiometric
imaging of Fura-2AM (F340/F380). Error bars
indicate SE from the mean.
(B) WT, trpc1/, and casp11/ macrophages
were treated with LPS (100 ng/ml, red bars) for
10 hr or left untreated (blue bars). Intracellular Ca2+
was measured through ratiometric imaging of
Fura-2AM (F340/F380). Error bars indicate SE.IL-1b and IL-18 in response to E. coli (Figures 4B–4D). Since
TRPC1deficiency did not have any effect on caspase-1 cleavage,
as indicated by the normal appearance of the caspase-1 subunit
p20, we conclude that the cleavage of TRPC1 likely impacts
events downstream of caspase-1 activation, including the uncon-
ventional secretion pathway that is responsible for mature IL-1b
release. Interestingly, trpc1/ macrophages also showed
increased mature IL-1b release triggered by canonical NLRP3 in-
flammasome activators such as ATP, HLLOMe, and silica, which
is independent of caspase-11 (Kayagaki et al., 2011), but showed
no difference in caspase-1 cleavage (Figures 4E and 4F). We thus
conclude that LPS priming modulates the TRPC1 complexes by
both caspase-11-dependent and -independent, redundant
mechanisms. Notably, TRPC1 deficiency did not lead to any in-
crease in the levels of pro-IL-1b, or secretion of TNF-a following
LPS priming, ruling out a role of TRPC1 in TLR4 signaling (Figures
4C, 4F, and S3B). In addition, TRPC1-deficiency did not sensitize
cells to caspase-11-dependent pyroptosis following infection by
E. coli, or to caspase-1-dependent pyroptosis induced by
canonical stimuli, including ATP and HLLOMe (Figures S3C–
S3F), supporting the notion that pyroptosis occurs independently
of TRPC1 degradation.
DISCUSSION
In this study, we describe the involvement of the cationic channel
subunit TRPC1 in promoting mature IL-1b release upon inactiva-
tion by caspase-11-mediated cleavage in response to Gram-
negative bacteria E. coli and LPS. Our identification of TRPC1
as a substrate for caspase-11, and evidence for its degradation
upon LPS-induced caspase-11 expression, suggest that the
TRPC1 complex is remodeled at the onset of inflammation and
plays a role in regulating innate immunity. Consistently, trpc1/
macrophages show increased secretion of mature IL-1b upon
infection by E. coli or stimulation with LPS together with extra-
cellular ATP or lysosome disruption, but show no defect in
caspase-1 cleavage or pyroptosis, suggesting that remodeling
of the TRPC1 complex regulates the unconventional secretion
pathway independently of caspase-1 activation. Thus, our
results demonstrate a role for caspase-11 in regulating IL-1b
secretion through the degradation of TRPC1 and the remodeling
of associated channel complexes independently of caspase-1.
As we reported previously (Kang et al., 2000), casp1/ mice,
which were independently generated by two separate groups,
do not express caspase-11 and accordingly should be referred
to as casp1/ casp11/ mice. Casp1/ Casp11Tg mice thatCeare deficient for caspase-1 and express caspase-11 were gener-
ated recently and helped to clarify the distinct functional roles
of caspase-1 and caspase-11 in innate immunity (Kayagaki
et al., 2011). Importantly, caspase-11, but not caspase-1, is crit-
ical for sensitivity to LPS-induced septic shock and confers
resistance against two pathogenic species of Gram-negative
Burkholderia; therefore, caspase-11 is an important regulator
of inflammation (Kayagaki et al., 2011; Rathinam et al., 2012;
Wang et al., 1996, 1998). Caspase-11 is unique among caspases
in that it is highly regulated at levels of transcription upon the acti-
vation of inflammatory responses (Wang et al., 1996, 1998). Pro-
caspase-11 is inducible upon stimulation of multiple ligands
involved in innate immunity, including LPS, IFNg, and type I
IFN (Broz et al., 2012; Gurung et al., 2012; Hur et al., 2001; Lee
et al., 2001; Lin et al., 2000; Rathinam et al., 2012; Schauvliege
et al., 2002; Wang et al., 1998; Yen and Ganea, 2009). Whether
expression of caspase-11 is sufficient for its autoactivation is
the subject of debate (Broz et al., 2012; Kang et al., 2000,
2004; Rathinam et al., 2012; Wang et al., 1998). Indeed, although
pro-caspase-11 induction by extracellular LPS or IFNg is suffi-
cient for its autoprocessing in the p30 form, an additional signal
that was recently identified to be cytosolic LPS is required to
trigger caspase-11-dependent pyroptosis and caspase-1 activ-
ity (Broz et al., 2012; Hagar et al., 2013; Kayagaki et al., 2013;
Rathinam et al., 2012). However, due to the lack of a specific
caspase-11 activity assay and identification of a caspase-11-
specific substrate, caspase-11 activity per se was not assessed
in previous studies. Therefore, cytosolic LPS may also control
pyroptosis and caspase-1 activation by acting downstream of
caspase-11 activation. Detection of autoprocessed p30 demon-
strates that caspase-11 is active in macrophages treated with
extracellular LPS (Rathinam et al., 2012). In the present study,
we show that TRPC1 is degraded by caspase-11 in macro-
phages treated with extracellular LPS, demonstrating that cas-
pase-11 can be activated without triggering pyroptosis.
Despite the high interest in caspase-11, very few of its sub-
strates have been identified. Caspase-11 can control cell mobility
and intracellular vesicular traffickingbymodulating actincytoskel-
eton independently of its protease activity (Akhter et al., 2012; Li
et al., 2007).On theother hand, caspase-11 is capable of autopro-
cessing (Kang et al., 2000). In addition, direct cleavage of cas-
pase-3 by caspase-11 was shown to contribute to deleterious
cell death in several animal models of neurodegenerative disease
(Hisahara et al., 2001;Kanget al., 2000;Shibata et al., 2000).How-
ever, the requirement for caspase-3 in caspase-11-dependent
pyroptosis has not yet been investigated (Kang et al., 2002;ll Reports 6, 1122–1128, March 27, 2014 ª2014 The Authors 1125
Figure 4. TRPC1 Inhibits Mature IL-1b
Release
(A) Trpc1/ mice secrete more IL-1b than WT
mice in the serum following LPS challenge.WT and
trpc1/ mice were injected intraperitoneally with
LPS (4 mg/kg). The sera were harvested after 4 hr
(n = 6) or 8 hr (n = 8–9). IL-1b secretion in sera was
assessed by ELISA. Error bars represent SE.
Untreated mice were used as negative control ().
t test, *p < 0.05.
(B) Macrophages from WT, trpc1/, and
casp11/mice were infected with E. coli for 16 hr,
and secretion of mature IL-1b in the culture
supernatant was assessed by ELISA. Error bars
indicate SD from the mean.
(C and D) Caspase-11, caspase-1, IL-1b, IL-18
expression level, cleavage, and secretion were
assessed by western blotting of cell lysates and
TCA-precipitated culture media.
(E) Macrophages from WT, trpc1/, and
casp11/mice were treated with LPS (100 ng/ml,
8 hr) followed by ATP (30 min), HLLOMe (30 min),
or silica (2 hr) at the indicated concentrations.
Mature IL-1b in the culture supernatant was
assessed by ELISA. Error bars indicate SD.
(F) Caspase-11, caspase-1, IL-1b expression
level, cleavage, and secretion were assessed by
western blot on cell lysates and TCA-precipitated
culture media.
See also Figure S3.Kayagaki et al., 2011). Lastly, the molecular mechanism of
caspase-11-dependent caspase-1 activation downstream of
noncanonical NLRP3 activators is unknown. Although caspase-
11 associates with caspase-1, caspase-1 is not a direct substrate
for caspase-11 (Wang et al., 1998). Thus, TRPC1 constitutes the
only noncaspase substrate for caspase-11 identified so far.
TRPC1 assembles with other TRPCs to form heterotetrameric
cation-permeable channels with current characteristics different
from those of homotetramers (Stru¨bing et al., 2001). In particular,
TRPC1 reduces the Ca2+ permeability of the respective channels
in homodimers while participating in the channel pore of at least
TRPC3, TRPC4, and TRPC5. TRPC1 also inhibits TRPV6 expres-
sion at the plasmamembrane (Schindl et al., 2012; Stru¨bing et al.,
2001). In neurons, TRPC1 formsa complexwithTRPC5 that local-
izes at the plasma membrane (Stru¨bing et al., 2001). However,
TRPC1 cannot be detected at the plasma membrane in macro-
phages where TRPC5 is not expressed (Kunert-Keil et al., 2006).
Given the complexity of these functional interactions, TRPC1
degradationduringan inflammatory responsemayalter thegating
properties of TRPC1-containing channels in the plasma or intra-
cellularmembranes to promoteunconventional protein secretion.
TRPC1 deficiency increases the secretion of mature IL-1b and
IL-18 by macrophages without affecting pyroptosis or the cleav-
age of caspase-1. Thus, caspase-11 regulates IL-1b and IL-18
secretion both at the cytokine maturation level through cas-1126 Cell Reports 6, 1122–1128, March 27, 2014 ª2014 The Authorspase-1 and at the extracellular release
level through TRPC1. Notably, TRPC1
deficiency potentiates not only caspase-
11-dependent IL-1b secretion but alsocaspase-11-independent IL-1b secretion, suggesting a poten-
tially wider role of TRPC1 in regulating secretion. Since TRPC1
degradation induced by LPS strictly depends on caspase-11,
LPS priming may modulate the channelosome through redun-
dant TRPC1- and caspase-11-independent mechanisms, and
bypass the caspase-11 requirement in unconventional protein
secretion in response to canonical NLRP3 stimulation. It would
be interesting to investigate the roles of caspase-11 and cas-
pase-1 in modulating other TRP channel activities in other in-
flammatory responses.
Taken together, our data point to a role of cationic channels in
the downstream process of unconventional secretion of IL-1b
and IL-18, and suggest that in addition to its already described
regulatory functions in the cytoskeleton, cell death, and cas-
pase-1 activation, caspase-11 controls IL-1b and IL-18 release
by modulating the cationic channel composition of the cell.
Our results also suggest a possible role for the TRPC1-associ-
ated channelosome in regulating unconventional secretion in
general, which needs to be investigated in future studies.EXPERIMENTAL PROCEDURES
Mice
C57B6, casp11/ (Wang et al., 1998), casp1/ mice deficient for both cas-
pase-1 and caspase-11 (casp1/ casp11/ mice) (Kang et al., 2000; Kuida
et al., 1995), and trpc1/ (Liu et al., 2007) mice were housed at the Warren
Alpert Animal Facility (Harvard Medical School) and Children’s Hospital Animal
Facility under specific pathogen-free conditions. Experiments were performed
in accordance with federal and institutional guidelines. The mice received food
and water ad libitum. Inflammatory peritoneal macrophages were elicited by
intraperitoneal injection of 0.75 ml thioglycolate broth and harvested by perito-
neal wash 4 days later.
Cell-Growth Conditions
HEK293T and LN-18 cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) and DMEM/F12 (GIBCO), respectively, supplemented with
13 penicillin/streptomycin (PS; GIBCO) and 10% fetal bovine serum (FBS;
GIBCO). Inflammatory peritoneal macrophages were cultured at 0.5–1 3
106 cells/ml in DMEM (GIBCO) supplemented with 13 PS and 10% FBS.
For all E. coli infection experiments, cells were grown in the absence of
PS. For trichloroacetic acid (TCA) precipitation of the media, cells were rinsed
and treated in DMEM+PS without serum.
Activation of the Inflammasome
E. coli (strain J53) were grown in lysogeny broth (LB) to log expansion phase,
resuspended in PBS, and added to macrophages. For IL-1b secretion assay,
gentamycin (50 mg/ml) was added 1.5 hr after infection and supernatant was
collected after a total of 16 hr following infection.
Constructs
Constructs coding for FLAG-caspase-11, FLAG-caspase-11CARD98 (aa
1–98), FLAG-caspase-11CARD103 (aa 1–103), FLAG-caspase-11p30,
FLAG-caspase-11p10, pcDNA-IL-1b, and pcDNA-Casp11C255G were previ-
ously described (Li et al., 2008). FLAG-caspase-11p20 (aa 79–285) was cloned
in pFLAG3X. HA-TRPC1, HA-TRPC1DC (deleted of the C-terminal domain, aa
1–649), HA-TRPC2, HA-TRPC3, HA-TRPC4, HA-TRPC5, and HA-TRPC6 were
kind gifts from P.F. Worley and J. Yuan (Yuan et al., 2003). HA-TRPC1-N
(N-terminal domain, aa 1–315), HA-TRPC1DN (deleted of the N-terminal
domain, aa 306–760), HA-TRPC1-TM (transmembrane domain, aa 306–613)
were cloned following PCR amplification.
Reagents
The following reagents were used: LPS from E. coli 0111:B4, ATP, and
nigericin (Sigma-Aldrich); silica (MIN-U-SIL 5; U.S. Silica); HLLOMe (Chem-
Impex International); z-VAD-fmk (Alexis); and IDUN-6556 (Linton et al., 2005).
Immunoprecipitation
For coimmunoprecipitation experiments, HEK293T cells were lysed in lysis
buffer (Tris HCl, pH 7.6 50 mM, NaCl 400 mM, NP-40 1%, PMSF 1 mM, and
protease inhibitors). HA-TRPC1 and FLAG-caspase-11 were immunoprecipi-
tated with anti-HA and anti-FLAG M2 agarose beads (Sigma-Aldrich), respec-
tively, for 4 hr at 4C. Immunoprecipitations were washed in lysis buffer and
proteins were eluted in Laemmli sample buffer 23. For anti-TRPC1 immuno-
precipitation, 5 3 106 macrophages were lysed in RIPA buffer. TRPC1 was
immunoprecipitated using protein A/G UltraLink resin (Thermo Scientific)
and anti-TRPC1 antibody (Millipore), and eluted in Laemmli sample buffer.
Transfection
HEK293T cells were transfected using the CaCl2 procedure. LN-18 cells were
transfected using transIT-LT1 transfection reagent (Mirus Bio).
Western Blot Analysis
Samples were analyzed by SDS-PAGE, transferred to PVDF membranes,
blocked, and probed according to standard procedures. The following
antibodies were used: anti-caspase-11 (Wang et al., 1998), anti-caspase-1
(Wang et al., 1998), anti-HA (Santa Cruz biotechnology), anti-FLAG M2
(Sigma-Aldrich), anti-TRPC1 (Millipore), anti-actin (Millipore), anti-IL-1b
(R&D Systems), anti-IL-18 (MBL), and anti-laminB (Santa Cruz).
In Vitro Caspase Cleavage Assay
In vitro production of 35S-labeled TRPC1 and IL-1bwas performed using TNT-
coupled transcription/translation kits (Promega). Purification of recombinantCeCaspase-11 p30 and in vitro cleavage assay by recombinant Caspase-11
p30 or active humanCaspase-1 (p30; Chemicon International) were performed
as described previously (Kang et al., 2000).
ELISA
In vitro secretion of IL-1b and TNF-a in macrophage culture supernatants was
measured using mouse IL-1b/IL-1F2 and TNF-a DuoSet kits (R&D Systems).
In vivo secretion of IL-1b in the serum was assessed using the mouse IL-1b/
IL-1F2 Quantikine kit (R&D).
Intracellular Ca2+ Measurement
Cells were loaded with the ratiometric Ca2+ indicator Fura-2/AM in Opti-MEM
(at 37C, 5% CO2) for 30 min, washed, and incubated for an additional 15 min
prior to imaging. Ca2+ imaging was performed in Ringer’s solution containing
2 mM Ca2+. Excitation was carried out at 340 nm and 380 nm using a Lambda
DG4 Ultra High Speed Wavelength Switcher (Sutter Instrument), and emission
was collected at 510 ± 10 nm using a Hamamatsu Orca R2 CCD camera and
Slidebook data acquisition software.
Cytotoxicity Assay
Cell death was measured as the percentage of lactate dehydrogenase (LDH)
release according to standard protocols. DMEM+10% FBS was used as the
blank control, and supernatants of control cells treated with Triton X-100
0.01% were used to measure total LDH release. Cell death was measured
by propidium iodide (PI) incorporation. PI (1 mg/ml) was added to the cell cul-
ture media, and cells were observed by live imaging using a Nikon Ti inverted
microscope equipped with a 103 Plan Apo NA 0.3 objective lens. Images were
acquired with a Hamamatsu ORCA-R2 cooled CCD camera controlled with
MetaMorph 7 software (Molecular Devices).
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